Radiotherapy Highlights from 2018 WCLC and ASTRO 2018 Annual Meeting

Overview

This one hour webinar will feature two presentations and a question/answer session:

Lung Cancer Science Highlights from the 2018 ASTRO Annual Meeting - Maria Werner-Wasik
This presentation will assess recent trials of immunotherapy as they pertain to Stage III NSCLC patients.  Also, the role of local ablative radiotherapy will be highlighted in view of the results of the SABR COMET study.  Prospective data on PET-adjusted adaptive therapy will also be discussed.

Radiotherapy Advances from the 2018 IASLC World Conference on Lung Cancer - Shankar Siva
This presentation will focus on overall survival and pneumonitis from the PACIFIC phase III study, abstracts on local consolidation therapy after systemic therapy, and finally, pathological
response rates after radiotherapy in SBRT and locally advanced disease.

Following the presentations there will be ample opportunity for the audience to submit questions and comments to the faculty via internet chat.

Date
Nov 20, 2018 -
Nov 20, 2018
Location

Online

Maria Werner-Wasik, MD, FASTRO
Walter J. Curran Professor of Radiation Oncology, Department of Radiation Oncology, Enterprise Vice Chair for Radiation Oncology, Contact PI for NRG Oncology-Jefferson, University Hospitals and, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

Shankar Siva, PhD, MBBS, FRANZCR
Associate Professor, Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

Maria Werner-Wasik, MD, FASTRO
Walter J. Curran Professor of Radiation Oncology, Department of Radiation Oncology, Enterprise Vice Chair for Radiation Oncology, Contact PI for NRG Oncology-Jefferson, University Hospitals and, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

Shankar Siva, PhD, MBBS, FRANZCR
Associate Professor, Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

Share